Star Wars Zero Company Studio Tries To Bring Back As Many Furloughed Devs 'As Possible' Following 'Unexpected Business Developments Outside Of Our Control'
AMO Pharma in Collaboration with Population Health Research Institute (PHRI) and Venca Research Inc. Announces FDA Advice on Potential Phase 3 Development Path for AMO-02 in Treatment of Arrhythmogenic Cardiomyopathy (ACM)